top of page
Section Background High-Res.jpg
Section Background High-Res.jpg

CONFERENCES

Medical Think Tank Evaluation

Thank you for attending the 2025 National PH Medical Think Tank!


Your feedback is vital in helping us improve future events and ensure we continue to provide relevant, engaging, and impactful programming for the PH community.

​

Please take a few minutes to complete the evaluations below.

Think Tank.jpg

Overall Event Evaluation​

​

Start by sharing your thoughts on the event as a whole:

Session Evaluations​

​

To give us feedback on specific sessions, simply click the links below. Please complete evaluations for each session you attended.

Thursday:

​

Female sex and pulmonary hypertension

Dr. Steven Kawut, University of Pennsylvania 


Why is my patient short of breath? Mechanisms of residual dyspnea post pulmonary embolism

Dr. Devin Phillips, York University 


Updates from the Canadian Pulmonary Hypertension Registry
Dr. Nathan Brunner, University of British Columbia; Freda Tom 


Biomarkers in pulmonary hypertension
Dr. Athénaïs Boucly, Université Paris-Saclay 


Pulmonary veno-occlusive disease 
Dr. Duncan J. Stewart, University of Ottawa Heart Institute 


Inflammatory mechanisms in pulmonary arterial hypertension – basic and translational approaches
Dr. Neil Goldenberg, University of Toronto 


The importance of blood vessels in the progression of pulmonary fibrosis
Dr. Martin Kolb, McMaster University 

 

 

Friday Morning:


Keynote: Big data in pulmonary hypertension: Looking backward and forward
Dr. Steven Kawut, University of Pennsylvania 

 

Anti-remodeling agents in PAH: A double-edged sword
Dr. Sébastien Bonnet, Université Laval 
 

Pulmonary hypertension: What’s in a name?
Dr. George Chandy, University of Ottawa Heart Institute 


Hemodynamic phenotyping of pulmonary hypertension
Dr. Susanna Mak, University of Toronto 


Pulmonary capillary recruitment: a way of life
Dr. David Langleben, McGill University 


Assessment of right ventricular function in pediatric pulmonary hypertension
Dr. Mark Friedberg, Hospital for Sick Children 

​

 

Friday Afternoon:


Setting treatment goals: an evidence-based and personalized approach
Dr. Jason Weatherald, University of Alberta 


Treatment strategies for Group 1 pulmonary hypertension
Dr. Sanjay Mehta, Western University 


Keynote: Understanding heterogeneity of treatment effects
Dr. Athénaïs Boucly, Université Paris-Saclay 


Topics in Group 3 pulmonary hypertension
Dr. Sarah MacIsaac, Dalhousie University 


Interactive case study in acute RV failure
Dr. John Granton, University Health Network 


What lies ahead?
Dr. Steeve Provencher, Université Laval â€‹

Why Your Feedback Matters​
​

Your feedback helps us make the Think Tank stronger each year. By sharing your thoughts, you guide us in refining session topics and formats, improving the experience for both in-person and virtual attendees, and providing meaningful input to our speakers and organizers. Most importantly, your reflections shape the future of PH knowledge exchange in Canada.

​

Thank you for taking the time to share your thoughts and helping us drive change and inspire hope!

PHA Canada

408 - 55 Water Street

Office 8928

Vancouver, BC, V6B 1A1

Email: info@phacanada.ca

Phone: 604-682-1036

Toll Free: 1-877-774-2226

  • Instagram
  • Facebook
  • X
  • LinkedIn
  • Youtube

Charitable Registration # 872050224RR0001

Copyright 2025 PHA CANADA, ALL RIGHTS RESERVED   |   Website created by Creativibe   |   Powered by raisin

bottom of page